인쇄하기
취소

Effectiveness and cost-effectiveness of Crestor 5 mg are verified, AstraZeneca Korea says

Published: 2013-08-21 07:00:00
Updated: 2013-08-21 07:00:00
In the previous clinical trial of 1,851 Korean patients with dyslipidemia, Crestor 5 mg (rosuvastatin) is more effective and cost-effective in lowering low-density lipoprotein cholesterol (LDL-C) and in attainment of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) LDL-C goal compared with atorvastatin or simvastatin among high-risk patients, according to Astr...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.